These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38820971)

  • 1. Fully human chitinase-3 like-1 monoclonal antibody inhibits tumor growth, fibrosis, angiogenesis, and immune cell remodeling in lung, pancreatic, and colorectal cancers.
    Su PC; Chen CY; Yu MH; Kuo IY; Yang PS; Hsu CH; Hou YC; Hsieh HT; Chang CP; Shan YS; Wang YC
    Biomed Pharmacother; 2024 Jul; 176():116825. PubMed ID: 38820971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer.
    Kawada M; Seno H; Kanda K; Nakanishi Y; Akitake R; Komekado H; Kawada K; Sakai Y; Mizoguchi E; Chiba T
    Oncogene; 2012 Jun; 31(26):3111-23. PubMed ID: 22056877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitinase 3-like 1 secreted from cancer-associated fibroblasts promotes tumor angiogenesis via interleukin-8 secretion in colorectal cancer.
    Watanabe K; Shiga K; Maeda A; Harata S; Yanagita T; Suzuki T; Ushigome H; Maeda Y; Hirokawa T; Ogawa R; Hara M; Takahashi H; Matsuo Y; Mitsui A; Kimura M; Takiguchi S
    Int J Oncol; 2022 Jan; 60(1):. PubMed ID: 34913066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting protumor factor chitinase-3-like-1 secreted by Rab37 vesicles for cancer immunotherapy.
    Yang PS; Yu MH; Hou YC; Chang CP; Lin SC; Kuo IY; Su PC; Cheng HC; Su WC; Shan YS; Wang YC
    Theranostics; 2022; 12(1):340-361. PubMed ID: 34987649
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-tumor activity of a novel monoclonal antibody, NPC-1C, optimized for recognition of tumor antigen MUC5AC variant in preclinical models.
    Patel SP; Bristol A; Saric O; Wang XP; Dubeykovskiy A; Arlen PM; Morse MA
    Cancer Immunol Immunother; 2013 Jun; 62(6):1011-9. PubMed ID: 23591984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection and Characterization of YKL-40-Targeting Monoclonal Antibodies from Human Synthetic Fab Phage Display Libraries.
    Kang K; Kim K; Lee SR; Kim Y; Lee JE; Lee YS; Lim JH; Lim CS; Kim YJ; Baek SI; Song DH; Hong JT; Kim DY
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32883029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 35 Expression Correlates With Microvessel Density in Pancreatic Ductal Adenocarcinoma, Recruits Monocytes, and Promotes Growth and Angiogenesis of Xenograft Tumors in Mice.
    Huang C; Li Z; Li N; Li Y; Chang A; Zhao T; Wang X; Wang H; Gao S; Yang S; Hao J; Ren H
    Gastroenterology; 2018 Feb; 154(3):675-688. PubMed ID: 28989066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
    Ding C; Li L; Yang T; Fan X; Wu G
    BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of metastasis through inhibition of chitinase 3-like 1 expression by miR-125a-3p-mediated up-regulation of USF1.
    Kim KC; Yun J; Son DJ; Kim JY; Jung JK; Choi JS; Kim YR; Song JK; Kim SY; Kang SK; Shin DH; Roh YS; Han SB; Hong JT
    Theranostics; 2018; 8(16):4409-4428. PubMed ID: 30214629
    [No Abstract]   [Full Text] [Related]  

  • 10. Chitinase 3-like-1 and fibronectin in the cargo of extracellular vesicles shed by human macrophages influence pancreatic cancer cellular response to gemcitabine.
    Xavier CPR; Castro I; Caires HR; Ferreira D; Cavadas B; Pereira L; Santos LL; Oliveira MJ; Vasconcelos MH
    Cancer Lett; 2021 Mar; 501():210-223. PubMed ID: 33212158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitinase 3 like 1 suppresses the stability and activity of p53 to promote lung tumorigenesis.
    Park KR; Yun HM; Yoo K; Ham YW; Han SB; Hong JT
    Cell Commun Signal; 2020 Mar; 18(1):5. PubMed ID: 32127023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A humanized Anti-YKL-40 antibody inhibits tumor development.
    Yu H; Wang Z; Zhu B; Jia Z; Luo J; Han X; Chen H; Shao R
    Biochem Pharmacol; 2024 Jul; 225():116335. PubMed ID: 38824968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer.
    Dineen SP; Sullivan LA; Beck AW; Miller AF; Carbon JG; Mamluk R; Wong H; Brekken RA
    BMC Cancer; 2008 Nov; 8():352. PubMed ID: 19038046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma.
    Moldenhauer G; Salnikov AV; Lüttgau S; Herr I; Anderl J; Faulstich H
    J Natl Cancer Inst; 2012 Apr; 104(8):622-34. PubMed ID: 22457476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers.
    Faibish M; Francescone R; Bentley B; Yan W; Shao R
    Mol Cancer Ther; 2011 May; 10(5):742-51. PubMed ID: 21357475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of Chitinase 3-Like-1 Inhibits Cell Proliferation, Promotes Apoptosis, and Enhances Effect of Anti-Programmed Death Ligand 1 (PD-L1) in Diffuse Large B Cell Lymphoma Cells.
    Yang X; Fang D; Li M; Chen J; Cheng Y; Luo J
    Med Sci Monit; 2021 Mar; 27():e929431. PubMed ID: 33764958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Monoclonal Antibody Targets Mucin1 and Attenuates Growth in Pancreatic Cancer Model.
    Wu G; Maharjan S; Kim D; Kim JN; Park BK; Koh H; Moon K; Lee Y; Kwon HJ
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29987260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts.
    Capasso A; Lang J; Pitts TM; Jordan KR; Lieu CH; Davis SL; Diamond JR; Kopetz S; Barbee J; Peterson J; Freed BM; Yacob BW; Bagby SM; Messersmith WA; Slansky JE; Pelanda R; Eckhardt SG
    J Immunother Cancer; 2019 Feb; 7(1):37. PubMed ID: 30736857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer.
    Aikawa T; Gunn J; Spong SM; Klaus SJ; Korc M
    Mol Cancer Ther; 2006 May; 5(5):1108-16. PubMed ID: 16731742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis and Validation of Human Targets and Treatments Using a Hepatocellular Carcinoma-Immune Humanized Mouse Model.
    Zhao Y; Wang J; Liu WN; Fong SY; Shuen TWH; Liu M; Harden S; Tan SY; Cheng JY; Tan WWS; Chan JKY; Chee CE; Lee GH; Toh HC; Lim SG; Wan Y; Chen Q
    Hepatology; 2021 Sep; 74(3):1395-1410. PubMed ID: 33738839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.